Research Paper Volume 16, Issue 1 pp 820—843
Prognostic implication of a novel lactate score correlating with immunotherapeutic responses in pan-cancer
Figure 5. The prognostic value of lactate score in pan-cancers. (A) Lactate score correlated with overall survival in BRCA, LIHC, MESO, OV, SARC and SKCM. (B) The KM plot of patients with high, middle and low lactate score in BRCA. (C) The KM plot of patients with high, middle and low lactate score in MESO. BRCA: breast invasive carcinoma; LIHC: liver hepatocellular carcinoma; MESO: mesothelioma; OV: ovarian cancer; SARC: sarcoma; SKCM: skin cutaneous melanoma.